A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
Oral cancer poses a significant global health threat, often diagnosed late with high mortality rates. Early detection through routine dental screenings is crucial for improved survival.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback